Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 1, 2009, Pages 39-44

  Alffenaar, J W C ^a   Wessels, A M A ^a   van Hateren, K ^a   Greijdanus, B ^a   Kosterink, J G W ^a   Uges, D R A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Azole antifungal agent; LC MS MS; Pharmacokinetics; Routine; Therapeutic drug monitoring

Indexed keywords

ANTIFUNGAL AGENTS; ANTIFUNGAL DRUGS; BIOANALYTICAL METHODS; CLINICAL PHARMACOKINETICS; DRUG-DRUG INTERACTIONS; FLUCONAZOLE; FOOD AND DRUG ADMINISTRATION; FUNGAL INFECTION; HUMAN SERUM; ITRACONAZOLE; LC/MS/MS; LIMIT OF QUANTIFICATIONS; METHOD OF ANALYSIS; REPRODUCIBILITIES; ROUTINE MONITORING; SERUM CONCENTRATION; SERUM LEVELS; THERAPEUTIC DRUG MONITORING; VORICONAZOLE;

BODY FLUIDS; DRUG PRODUCTS; DRUG THERAPY; FLUORINE CONTAINING POLYMERS; FUNGICIDES; PATIENT MONITORING; PHARMACOKINETICS;

DRUG INTERACTIONS;

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; VALIDATION PROCESS;

ANALYSIS OF VARIANCE; ANTIFUNGAL AGENTS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; DRUG STABILITY; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TRIAZOLES;

EID: 71249154511     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.11.017     Document Type: Article

References (45)

1. Cuenca-Estrella M., Bernal-Martinez L., Buitrago M.J., Castelli M.V., Gomez-Lopez A., Zaragoza O., and Rodriguez-Tudela J.L. Int. J. Antimicrob. Agents 32 Suppl. 2 (2008) S143
2. Herbrecht R., Denning D.W., Patterson T.F., Bennett J.E., Greene R.E., Oestmann J.W., Kern W.V., Marr K.A., Ribaud P., Lortholary O., Sylvester R., Rubin R.H., Wingard J.R., Stark P., Durand C., Caillot D., Thiel E., Chandrasekar P.H., Hodges M.R., Schlamm H.T., Troke P.F., and de Pauw B. N. Engl. J. Med. 347 (2002) 408
3. pfizer, 2002.
4. Cornely O.A., Maertens J., Winston D.J., Perfect J., Ullmann A.J., Walsh T.J., Helfgott D., Holowiecki J., Stockelberg D., Goh Y.T., Petrini M., Hardalo C., Suresh R., and ngulo-Gonzalez D. N. Engl. J. Med. 356 (2007) 348
5. Prentice A.G., Glasmacher A., and Djulbegovic B. Br. J. Haematol. 132 (2006) 656
6. Greenberg R.N., Mullane K., van Burik J.A., Raad I., Abzug M.J., Anstead G., Herbrecht R., Langston A., Marr K.A., Schiller G., Schuster M., Wingard J.R., Gonzalez C.E., Revankar S.G., Corcoran G., Kryscio R.J., and Hare R. Antimicrob. Agents Chemother. 50 (2006) 126
7. Walsh T.J., Raad I., Patterson T.F., Chandrasekar P., Donowitz G.R., Graybill R., Greene R.E., Hachem R., Hadley S., Herbrecht R., Langston A., Louie A., Ribaud P., Segal B.H., Stevens D.A., van Burik J.A., White C.S., Corcoran G., Gogate J., Krishna G., Pedicone L., Hardalo C., and Perfect J.R. Clin. Infect. Dis. 44 (2007) 2
8. Poirier J.M., and Cheymol G. Clin. Pharmacokinet. 35 (1998) 461
9. Hope W.W., Billaud E.M., Lestner J., and Denning D.W. Curr. Opin. Infect. Dis. 21 (2008) 580
10. Garey K.W., Rege M., Pai M.P., Mingo D.E., Suda K.J., Turpin R.S., and Bearden D.T. Clin. Infect. Dis. 43 (2006) 25
11. Pascual A., Calandra T., Bolay S., Buclin T., Bille J., and Marchetti O. Clin. Infect. Dis. 46 (2008) 201
12. Smith J., Safdar N., Knasinski V., Simmons W., Bhavnani S.M., Ambrose P.G., and Andes D. Antimicrob. Agents Chemother. 50 (2006) 1570
13. Boyd A.E., Modi S., Howard S.J., Moore C.B., Keevil B.G., and Denning D.W. Clin. Infect. Dis. 39 (2004) 1241
14. Imhof A., Schaer D.J., Schanz U., and Schwarz U. Swiss. Med. Wkly. 136 (2006) 739
15. Bruggemann R.J., Donnelly J.P., Aarnoutse R.E., Warris A., Blijlevens N.M., Mouton J.W., Verweij P.E., and Burger D.M. Ther. Drug Monit. 30 4 (2008) 403-411
16. Buchkowsky S.S., Partovi N., and Ensom M.H. Ther. Drug Monit. 27 (2005) 322
17. Goodwin M.L., and Drew R.H. J. Antimicrob. Chemother. 61 (2008) 17
18. Hope W.W., and Denning D.W. Intern. Med. J. 34 (2004) 147
19. Smith J., and Andes D. Ther. Drug Monit. 30 (2008) 167
20. Trifilio S., Pennick G., Pi J., Zook J., Golf M., Kaniecki K., Singhal S., Williams S., Winter J., Tallman M., Gordon L., Frankfurt O., Evens A., and Mehta J. Cancer 109 (2007) 1532
21. Walsh T.J., Anaissie E.J., Denning D.W., Herbrecht R., Kontoyiannis D.P., Marr K.A., Morrison V.A., Segal B.H., Steinbach W.J., Stevens D.A., van Burik J.A., Wingard J.R., and Patterson T.F. Clin. Infect. Dis. 46 (2008) 327
22. Chapman S.W., Dismukes W.E., Proia L.A., Bradsher R.W., Pappas P.G., Threlkeld M.G., and Kauffman C.A. Clin. Infect. Dis. 46 (2008) 1801
23. U.S. Department of Healt and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM). Bioanalytical Method Validation (2001)
24. Pasqualotto A.C., Shah M., Wynn R., and Denning D.W. Arch. Dis. Child. 93 (2008) 578
25. Steinbach W.J. Pediatr. Infect. Dis. J. 24 (2005) 358
26. Prentice A.G., and Glasmacher A. J. Antimicrob. Chemother. 56 Suppl. 1 (2005) i17
27. Bruggemann R.J., Touw D.J., Aarnoutse R.E., Verweij P.E., and Burger D.M. Antimicrob. Agents Chemother. (2008)
28. Alffenaar J.W., de Vos T., Uges D.R., and Daenen S.M. Br. J. Clin. Pharmacol. 67 (2008) 262
29. Bruggemann R.J., Alffenaar J.W., Blijlevens N.M., Billaud E.M., Kosterink J.G., Verweij P.E., and Burger D.M. Clin. Infect. Dis. 48 (2009) 1441
30. Alffenaar J.W.C., van der Elst K.C.M., Uges D.R.A., Kosterink J.G.W., and Daenen S.M.G.J. Br. J. Clin. Pharmacol. 68 3 (2009) 462-463
31. Alffenaar J.W., Doedens R.A., Groninger E., and Kosterink J.G. Pediatr. Infect. Dis. J. 27 (2008) 189
32. Alffenaar J.W., van Assen S., van der Werf T.S., Kosterink J.G., and Uges D.R. Clin. Infect. Dis. 48 (2009) 839
33. Yao M., Chen L., and Srinivas N.R. J. Chromatogr. B Biomed. Sci. Appl. 752 (2001) 9
34. Vogeser M., Spohrer U., and Schiel X. Clin. Chem. Lab. Med. 41 (2003) 915
35. Vogeser M., Schiel X., and Spohrer U. Clin. Chem. Lab. Med. 43 (2005) 730
36. Bafeltowska J.J., and Buszman E. Chemotherapy 51 (2005) 370
37. Carrier A., and Parent J. J. Chromatogr. B Biomed. Sci. Appl. 745 (2000) 413
38. Kousoulos C., Tsatsou G., Apostolou C., Dotsikas Y., and Loukas Y.L. Anal. Bioanal. Chem. 384 (2006) 199
39. Moraes L.A., Lerner F.E., Moraes M.E., Moraes M.O., Corso G., and de N.G. Ther. Drug Monit. 21 (1999) 200
40. Shen J.X., Krishna G., and Hayes R.N. J. Pharm. Biomed. Anal. 43 (2007) 228
41. Conte Jr. J.E., Golden J.A., Krishna G., McIver M., Little E., and Zurlinden E. Antimicrob. Agents Chemother. 53 (2009) 703
42. Eerkes A., Shou W.Z., and Naidong W. J. Pharm. Biomed. Anal. 31 (2003) 917
43. Keevil B.G., Newman S., Lockhart S., Howard S.J., Moore C.B., and Denning D.W. Ther. Drug Monit. 26 (2004) 650
44. Araujo B.V., Conrado D.J., Palma E.C., and Dalla C.T. J. Pharm. Biomed. Anal. 44 (2007) 985
45. Krishna G., Sansone-Parsons A., Martinho M., Kantesaria B., and Pedicone L. Antimicrob. Agents Chemother. 51 (2007) 812